 RefDoc 
Bienvenue - Welcome 
Refdoc est un service / is powered by 
	www.cnrs.fr   www.inist.fr 
 
         Bookmark and Share 
	Haut 
	 
 
Découvrir / Discover 
Refdoc 
EXPORT 
Mendeley   to Mendeley 
EndNote   to EndNote 
 
INIST Diffusion 
 
2, Allée du Parc de Brabois 
F-54514 Vandoeuvre-lès-Nancy 
Cedex 
France 
Phone: +33 (0)3 83 50 46 64 
Fax: +33 (0)3 83 50 46 66 
	Nous contacter 
Contact us 
	 
Faire une nouvelle recherche 
Make a new search 
Lancer la recherche 
		 
	 
Commander ce document 	ok 
	 
Order this document 	ok 
 
	 
	 
Titre du document / Document title 
Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis 
Auteur(s) / Author(s) 
NAGANO Isao (1) ; ILIEVA Hristelina (1) ; SHIOTE Mito (1) ; MURAKAMI Tetsuro (1) ; YOKOYAMA Masataka (2) ; SHOJI Mikio (1) ; ABE Koji (1) ; 
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s) 
(1) Department of Neurology, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama, 700-8558, JAPON 
(2) Department of Anesthesiology, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama, 700-8558, JAPON 
Résumé / Abstract 
Insulin-like growth factor (IGF)-1 has been shown to have a protective effect on motor neurons both in vitro and in vivo, but has limited efficacy in patients with amyotrophic lateral sclerosis (ALS) when given subcutaneously. To examine the possible effectiveness of IGF-1 in a mouse model of familial ALS, transgenic mice expressing human Cu/Zn superoxide dismutase (SOD1) with a G93A mutation were treated by continuous IGF-1 delivery into the intrathecal space of the lumbar spinal cord. We found that the intrathecal administration of IGF-1 improved motor performance, delayed the onset of clinical disease, and extended survival in the G93A transgenic mice. Furthermore, it increased the expression of phosphorylated Akt and ERK in spinal motor neurons, and partially prevented motor neuron loss in these mice. Taken together, the results suggest that direct administration of IGF-1 into the intrathecal space may have a therapeutic benefit for ALS. 
Revue / Journal Title 
Journal of the neurological sciences     ISSN   0022-510X     CODEN  JNSCAG  
Source / Source 
2005, vol. 235, n o 1-2, pp. 61-68 [8 page(s) (article)] (50 ref.) 
Langue / Language 
Anglais 
Editeur / Publisher 
Elsevier, Amsterdam, PAYS-BAS  (1964) (Revue) 
Mots-clés anglais / English Keywords 
Central nervous system 
; 
Central nervous system disease 
; 
Spinal cord disease 
; 
Degenerative disease 
; 
Enzyme 
; 
Spinal cord 
; 
Mutation 
; 
Motor neuron 
; 
Extracellular signal-regulated protein kinase 
; 
Animal model 
; 
Insulin like growth factor 1 
; 
Intrathecal 
; 
Treatment 
; 
Amyotrophic lateral sclerosis 
; 
Nervous system diseases 
; 
Mots-clés français / French Keywords 
Système nerveux central 
; 
Système nerveux central pathologie 
; 
Moelle épinière pathologie 
; 
Maladie dégénérative 
; 
Enzyme 
; 
Moelle épinière 
; 
Mutation 
; 
Neurone moteur 
; 
Extracellular signal-regulated protein kinase 
; 
Modèle animal 
; 
Facteur croissance IGF1 
; 
Intrarachidien 
; 
Traitement 
; 
Sclérose latérale amyotrophique 
; 
Système nerveux pathologie 
; 
Mots-clés espagnols / Spanish Keywords 
Sistema nervioso central 
; 
Sistema nervosio central patología 
; 
Médula espinal patología 
; 
Enfermedad degenerativa 
; 
Enzima 
; 
Médula espinal 
; 
Mutación 
; 
Neurona motora 
; 
Extracellular signal-regulated protein kinase 
; 
Modelo animal 
; 
Factor crecimiento IGF1 
; 
Intratecal 
; 
Tratamiento 
; 
Esclerosis lateral amiotrófica 
; 
Sistema nervioso patología 
; 
Mots-clés d'auteur / Author Keywords 
Akt 
; 
Bcl-2 
; 
ERK 
; 
Motor neuron 
; 
SOD1 mutation 
; 
Spinal cord 
; 
Localisation / Location 
INIST-CNRS, Cote INIST : 12185, 35400013836078.0090 
 
Nº notice refdoc (ud4) : 16984088 
 
Commander ce document 	ok 
	 
Order this document 	ok 
 
	 
		 
 
Faire une nouvelle recherche 
Make a new search 
Lancer la recherche 
	Bas 
 
